DiaCarta to Become a Publicly Listed Company Through Merger with HH&L Acquisition Co.
HH&L Acquisition Co., a publicly traded special purpose acquisition company (SPAC) targeting the healthcare sector in Asia, and DiaCarta, Ltd., a precision molecular diagnostics company and developer of novel oncology and infectious disease tests, announced on October 14 that they have entered into a definitive business combination agreement. The transaction implies a pre-money equity value of $460 million for DiaCarta on a fully diluted basis. The transaction is expected to close in the first quarter of 2021 and will position DiaCarta to capitalize on significant future growth within existing and new markets. Upon closing of the transaction, the combined company will be listed on the... Read More »
DirectMed Parts & Service acquires ScanMed
Poway, California-based DirectMed Parts & Service acquired Omaha, Nebraska-based ScanMed. The terms of the deal were not disclosed. Founded in 2004, ScanMed is an MRI coil design, manufacturer and repair company with a record of designing and repairing thousands of MRI coils for GE Healthcare, Siemens, Philips and Canon/Toshiba systems. A portfolio company of NMS Capital, DirectMed Parts & Service is an aftermarket diagnostic imaging parts, systems and service provider with more than 60,000 parts in stock. The company repairs, supports and sells GE, Siemens, Philips and Canon/Toshiba MRI and CT parts to healthcare networks, imaging centers and independent service organizations... Read More »
Biomax Informatics AG Acquires LabVantage Solutions
Biomax Informatics AG, a management services organization, acquired LabVantage Solutions, Inc. The terms of the deal were not disclosed. Biomax Informatics offers software solutions for better decision-making and optimal knowledge management in the life sciences industry. It is based in Germany. LabVantage Solutions, Inc. is a provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower cost. According to the LevinPro HC database, this was the 102nd Labs deal of the year. This compares with 90 Labs deals reported between Jan. 1, 2021, and Oct. 13, 2021. Read More »
BioIVT Acquires Fidelis Research in Fourth Acquisition of 2022
BioIVT, a portfolio company of private equity firm Linden Capital Partners and formerly known as BioreclamationIVT, announced on September 26 its acquisition of Fidelis Research, a Sofia, Bulgaria-headquartered provider of biospecimen collection, laboratory processing and analysis, clinical research and patient support programs. Terms of the deal were not disclosed. With this acquisition, Westbury, New York-based BioIVT will be able to expand its support of precision medicine research in multiple therapeutic areas, most notably in oncology. Fidelis Research is an 85-site clinical biospecimen collection network in southeastern Europe. The company also has cell isolation capabilities and... Read More »
Pharos Capital Group Invests in Renal Care 360°
Pharos Capital Group, LLC, a middle-market private equity firm based in Dallas and Nashville, announced on September 12 a significant investment in Renal Care 360°, a nephrology practice and chronic care management company founded by renal care entrepreneur Joe Cashia. The size and terms of the transaction were not disclosed. This marks the fourth investment from Pharos’ latest flagship fund, Pharos Capital Partners IV, L.P. Pharos’ investment, along with additional equity investment from Renal Care 360°’s founding shareholders, will be used to support continued growth of the company’s RC360° Connected Care Program, geographic expansion through acquisitions and the... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
